Margaret Olinger, Chief Commercial Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 2,403 shares at $36.08 ($87K) on 2023-01-06, disclosed to the SEC on 2023-01-10.
Scheduled sale ($87k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.08 | 1,660 | $60K | 68.7% |
| 2 | $36.79 | 743 | $27K | 31.3% |
| Total | $36.30 avg | 2,403 | $87K | 100% |